FDA
-
-
-
-
-
-
-
Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Pulmonx Announces Closing of up to $60 Million Credit Facility
-
-
-
-
-
-
-
Pulmonx to Report Third Quarter 2025 Financial Results on October 29, 2025
-
-
-
-
-
-
-
Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference
-
-
-
-
-
-
-
Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference
-
-
-
-
-
-
-
Pulmonx Announces Presentation of Clinical Data from the AeriSealĀ® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024
-
-
-
-
-
-
-
Pulmonx Reports First Quarter 2024 Financial Results
-
334,274 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


